Hangzhou Alltest Biotech Co., Ltd. (688606.SS)
CNY 63.09
(-3.68%)
CNY 63.09
(-3.68%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 24.76 Million | 1.36 Billion | 923.87 Million | 622.71 Million | 91.53 Million | 18.6 Million |
| Net Income | 180.28 Million | 1.18 Billion | 765.68 Million | 679.22 Million | 78.41 Million | 56.42 Million |
| Depreciation & Amortization | 19.29 Million | 57.74 Million | 15.58 Million | 4.03 Million | 3.11 Million | 2.33 Million |
| Deferred income taxes | 16.26 Million | -46.1 Million | 3.44 Million | -2.17 Million | -116.3 Thousand | -775.9 Thousand |
| Stock-based compensation | 20.69 Million | 10.01 Million | - | - | - | - |
| Change in working capital | -185.29 Million | -151.52 Million | 153.12 Million | -63.91 Million | 11.35 Million | -45.44 Million |
| Other non-cash items | 5.57 Million | 304.1 Million | -10.52 Million | 3.36 Million | -1.35 Million | 5.28 Million |
| Investing Cash Flow | -140.66 Million | -1.26 Billion | -531.35 Million | -384.91 Million | -40.38 Million | -69.62 Million |
| Investments in PPE | -533.49 Million | -270.23 Million | -140.12 Million | -37.1 Million | -15.08 Million | -34.66 Million |
| Acquisitions | 490.45 Thousand | -16.6 Million | 15.92 Thousand | 37.1 Million | 15.5 Million | - |
| Investment purchases | -1.4 Billion | -3.25 Billion | -1.17 Billion | -778 Million | -152 Million | -45 Million |
| Sales/Maturities of investments | 1.79 Billion | 2.28 Billion | 787.95 Million | 430.18 Million | 126.28 Million | 10.03 Million |
| Other Investing Activities | 392.82 Million | 20.5 Thousand | 0.26 | -37.1 Million | -15.08 Million | 0.49 |
| Financing Cash Flow | -558.79 Million | -361.9 Million | 1.51 Billion | -6.75 Million | - | 19.35 Million |
| Debt repayment | -16.38 Million | -34.43 Million | -12.64 Million | - | - | - |
| Dividends payments | -528.68 Million | -215.61 Million | -107.8 Million | - | - | - |
| Common Stock Repurchased | -22.64 Million | -115.55 Million | 52.01 Million | - | - | - |
| Common Stock Issuance | - | 149.99 Million | -39.37 Million | -6.75 Million | - | - |
| Other Financing Activities | -30.09 Million | -146.29 Million | 1.62 Billion | -6.75 Million | - | 19.35 Million |
| Accounts receivables | -14.05 Million | 129.52 Million | -124.24 Million | -90.36 Million | 20.33 Million | -44.86 Million |
| Accounts payables | -199.9 Million | -221.75 Million | 537.97 Million | 100.47 Million | 695.7 Thousand | 16 Million |
| Inventory | 12.39 Million | -13.19 Million | -264.05 Million | -71.84 Million | -9.56 Million | -15.81 Million |
| Other working capital | 20.69 Million | -46.1 Million | 3.44 Million | -2.17 Million | -116.26 Thousand | -29.63 Million |
| Cash at beginning of period | 1.98 Billion | 2.17 Billion | 285.54 Million | 62.92 Million | 11.94 Million | 43.26 Million |
| Cash at end of period | 1.31 Billion | 1.98 Billion | 2.17 Billion | 285.54 Million | 62.92 Million | 11.94 Million |
| Capital Expenditure | -533.49 Million | -270.23 Million | -140.12 Million | -37.1 Million | -15.08 Million | -34.66 Million |
| Effect of forex changes on cash | 9.47 Million | 67.85 Million | -18.72 Million | -8.43 Million | -163.12 Thousand | 356.45 Thousand |
| Net cash flow / Change in cash | -665.21 Million | -197.36 Million | 1.89 Billion | 222.61 Million | 50.98 Million | -31.31 Million |
| Free Cash Flow | -508.72 Million | 1.09 Billion | 783.75 Million | 585.6 Million | 76.44 Million | -16.06 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 73.64 Million | 79.09 Million | 44.78 Million | 180.28 Million | 78.48 Million | 30.38 Million |
| Depreciation & Amortization | - | 10.1 Million | 10.1 Million | 19.29 Million | 39.62 Million | -19.69 Million |
| Deferred income taxes | - | - | - | 16.26 Million | - | 20.56 Million |
| Stock-based compensation | - | - | - | 20.69 Million | 20.69 Million | -13.19 Million |
| Change in working capital | - | - | - | -185.29 Million | 19.03 Million | 12.27 Million |
| Other non-cash items | 16.12 Million | -216.05 Thousand | -5.7 Million | 5.57 Million | -78.48 Million | 5.22 Million |
| Investing Cash Flow | 207.39 Million | -282.35 Million | -76.25 Million | -140.66 Million | -194.3 Million | -352.75 Million |
| Investments in PPE | -51.12 Million | -55.75 Million | -70.62 Million | -533.49 Million | -70.23 Million | -197.82 Million |
| Acquisitions | 274.94 Thousand | 2.98 Million | 10.06 Thousand | 490.45 Thousand | -1.98 Million | 1.62 Million |
| Investment purchases | -345.53 Million | -768.42 Million | -872.05 Million | -1.4 Billion | -500.09 Million | -225.25 Million |
| Sales/Maturities of investments | 603.77 Million | 538.84 Million | 866.41 Million | 1.79 Billion | 379.2 Million | 67.5 Million |
| Other Investing Activities | 274.94 Thousand | 2.98 Million | -5.63 Million | 392.82 Million | -124.06 Million | 1.19 Million |
| Financing Cash Flow | -65.62 Million | -50.46 Million | -39.51 Million | -558.79 Million | -274.75 Thousand | -20.88 Million |
| Debt repayment | - | - | - | -16.38 Million | - | - |
| Dividends payments | -66.12 Million | -50.16 Million | - | -528.68 Million | -17.52 Thousand | - |
| Common Stock Repurchased | - | - | - | -22.64 Million | -22.64 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 498.77 Thousand | -301.62 Thousand | -39.51 Million | -30.09 Million | -257.22 Thousand | -20.88 Million |
| Accounts receivables | - | - | - | -14.05 Million | -14.05 Million | 13.19 Million |
| Accounts payables | - | - | - | -199.9 Million | - | 13.19 Million |
| Inventory | - | - | - | 12.39 Million | 12.39 Million | -918.14 Thousand |
| Other working capital | - | - | - | 20.69 Million | 20.69 Million | -13.19 Million |
| Cash at beginning of period | 972.82 Million | 1.23 Billion | 1.31 Billion | 1.98 Billion | 1.4 Billion | 1.74 Billion |
| Cash at end of period | 1.19 Billion | 972.82 Million | 1.23 Billion | 1.31 Billion | 1.31 Billion | 1.4 Billion |
| Capital Expenditure | -51.12 Million | -55.75 Million | -70.62 Million | -533.49 Million | -70.23 Million | -197.82 Million |
| Effect of forex changes on cash | -7.46 Million | 1.98 Million | 46.11 Thousand | 9.47 Million | -2.81 Million | -5.36 Million |
| Net cash flow / Change in cash | 223.27 Million | -267.16 Million | -76.63 Million | -665.21 Million | -88.59 Million | -343.45 Million |
| Free Cash Flow | 38.65 Million | 13.02 Million | -31.53 Million | -508.72 Million | 38.55 Million | -162.27 Million |
BAF
688050
FQVTF
EXXRF
MVI
BQST